NXGLW
NEXGEL, INC.
Key Financials
Revenue
$11.4M
↑ 31.5%
Net Income
$-3000000
↑ 8.6%
Gross Profit
$4.5M
↑ 64.1%
EPS (Diluted)
$-0.38
↑ 24.0%
Total Liabilities
$5.6M
↑ 13.6%
Total Assets
$10.5M
↓ 4.8%
Long-term Debt
$588000.00
↓ 14.2%
Shareholders' Equity
$4.5M
↓ 22.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 144 | 9/30/2026 | View on SEC |
| 8-K | 9/24/2026 | View on SEC |
| 8-K | 9/23/2026 | View on SEC |
| DEF 14A | 8/24/2026 | View on SEC |
| 8-K | 8/21/2026 | View on SEC |
| S-1 | 8/20/2026 | View on SEC |
| 8-K | 8/17/2026 | View on SEC |
| 10-Q | 8/17/2026 | View on SEC |
| NT 10-Q | 8/17/2026 | View on SEC |
| PRE 14A | 8/14/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NXGLW |
| Company Name | NEXGEL, INC. |
| CIK | 1468929 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 215 702-8550 |